Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Hatherill

Showing results (61-70 of 222) with videos related to

Pageof 23
Sort By:
Vaccine|June 1, 2025
Sample size efficiency of restricting participation in tuberculosis vaccine trials to interferon-gamma release assay-positive participantsFrank Cobelens, Puck T Pelzer, Gavin J Churchyard, et al.
Plos One|August 15, 2024
Detection of Mycobacterium tuberculosis from tongue swabs using sonication and sequence-specific hybridization captureAlexander J Yan, Alaina M Olson, Kris M Weigel, et al.
The Lancet. Infectious Diseases|March 21, 2026
Accelerating research and development of new vaccines against tuberculosis: 5-year progress on the global roadmapElly van Riet, Björn Corleis, Birgitte K Giersing, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 28, 2019
<sup>18</sup>F-FDG PET/CT as a Noninvasive Biomarker for Assessing Adequacy of Treatment and Predicting Relapse in Patients Treated for Pulmonary TuberculosisIsmaheel O Lawal, Bernard P Fourie, Matsontso Mathebula, et al.
BMJ (Clinical Research Ed.)|November 15, 2008
Efficacy of percutaneous versus intradermal BCG in the prevention of tuberculosis in South African infants: randomised trialAnthony Hawkridge, Mark Hatherill, Francesca Little, et al.
The Pediatric Infectious Disease Journal|November 19, 2011
Diagnostic features associated with culture of Mycobacterium tuberculosis among young children in a vaccine trial settingKany Kany A Luabeya, Humphrey Mulenga, Sizulu Moyo, et al.
Ebiomedicine|February 20, 2021
Immune profiling of Mycobacterium tuberculosis-specific T cells in recent and remote infectionCheleka A M Mpande, Virginie Rozot, Boitumelo Mosito, et al.
Vaccine|April 30, 2011
Phenotypic variability in childhood TB: implications for diagnostic endpoints in tuberculosis vaccine trialsHumphrey Mulenga, Sizulu Moyo, Lesley Workman, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|June 7, 2012
SATVI - after 10 years closing in on a new and better vaccine to prevent tuberculosisWillem A Hanekom, Anthony Hawkridge, Hassan Mahomed, et al.
The European Respiratory Journal|November 13, 2016
Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosisElisa Petruccioli, Thomas J Scriba, Linda Petrone, et al.
Pageof 23

Showing results (61-70 of 222) with videos related to

Sort By:
Pageof 23
Vaccine|June 1, 2025
Sample size efficiency of restricting participation in tuberculosis vaccine trials to interferon-gamma release assay-positive participantsFrank Cobelens, Puck T Pelzer, Gavin J Churchyard, et al.
Plos One|August 15, 2024
Detection of Mycobacterium tuberculosis from tongue swabs using sonication and sequence-specific hybridization captureAlexander J Yan, Alaina M Olson, Kris M Weigel, et al.
The Lancet. Infectious Diseases|March 21, 2026
Accelerating research and development of new vaccines against tuberculosis: 5-year progress on the global roadmapElly van Riet, Björn Corleis, Birgitte K Giersing, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 28, 2019
<sup>18</sup>F-FDG PET/CT as a Noninvasive Biomarker for Assessing Adequacy of Treatment and Predicting Relapse in Patients Treated for Pulmonary TuberculosisIsmaheel O Lawal, Bernard P Fourie, Matsontso Mathebula, et al.
BMJ (Clinical Research Ed.)|November 15, 2008
Efficacy of percutaneous versus intradermal BCG in the prevention of tuberculosis in South African infants: randomised trialAnthony Hawkridge, Mark Hatherill, Francesca Little, et al.
The Pediatric Infectious Disease Journal|November 19, 2011
Diagnostic features associated with culture of Mycobacterium tuberculosis among young children in a vaccine trial settingKany Kany A Luabeya, Humphrey Mulenga, Sizulu Moyo, et al.
Ebiomedicine|February 20, 2021
Immune profiling of Mycobacterium tuberculosis-specific T cells in recent and remote infectionCheleka A M Mpande, Virginie Rozot, Boitumelo Mosito, et al.
Vaccine|April 30, 2011
Phenotypic variability in childhood TB: implications for diagnostic endpoints in tuberculosis vaccine trialsHumphrey Mulenga, Sizulu Moyo, Lesley Workman, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|June 7, 2012
SATVI - after 10 years closing in on a new and better vaccine to prevent tuberculosisWillem A Hanekom, Anthony Hawkridge, Hassan Mahomed, et al.
The European Respiratory Journal|November 13, 2016
Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosisElisa Petruccioli, Thomas J Scriba, Linda Petrone, et al.
Pageof 23